Clinical Trial Update: Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating the efficacy and safety of alglucosidase alfa in Chinese patients with late-onset Pompe disease; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Alglucosidase alfa (alglucosidase alfa)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pompe's Disease | Phase 4 | Status: COMPLETED